Genomic Signatures Associated With Adverse Pathologic Features at Radical Prostatectomy

At the AUA 2024 Annual Meeting, Eric Li, MD, of Northwestern University, highlighted his recent analysis on the significance of adverse pathologic features at radical prostatectomy for active surveillance-eligible patients.

He expands on how Decipher genomic classifier, PTEN loss, and activated CD4 activity at diagnosis are associated with adverse pathologic features among these patients.